Isolation, Culture, and Characterization of Dental Pulp Stem Cells from Human Deciduous and Permanent Teeth
May 17th, 2024
This protocol emphasizes the extraction, culture, and preservation of multipotent stem cells from dental pulp through enzymatic digestion. Additionally, it demonstrates their potential to differentiate into osteoblasts, adipocytes, and chondrocytes, highlighting the importance of precision and consistency in the process.
Begin by securing the extracted human tooth in place with dental forceps. Then cut the tooth using a diamond disc connected to a dental handpiece and a water coolant. Using a dental excavator, remove the pulp tissue from the tooth.
Next, use a sterile surgical blade to carefully mince the pulp tissue into small fragments. Then place these fragments into a mini tissue grinder with PBS to form a homogenous mixture. Transfer the minced tissue fragments into a 15 milliliter tube and digest them using a mixture of collagenase type one and dispase.
Incubate the tissue in the enzyme mixture at 37 degrees Celsius for two hours. After incubation, neutralize the enzymes. Next, transfer the digested tissue to a 15 milliliter tube and spin at 300 G for five minutes at room temperature.
Then carefully discard the supernatant and re-suspend the pellet in fresh DMEM, supplemented with 10 to 20%FBS. For cell culture, carefully transfer the cell suspension to a 25 square centimeter culture flask. Incubate the cells at 37 degrees Celsius in 5%carbon dioxide.
After two to three days, using a sterile serological pipette, carefully aspirate the medium and replace it with a fresh medium. Next, for the characterization of DPSCs, turn on the flow cytometer and confirm the mesenchymal stem cell nature of the isolated cells. The successful differentiation of DPSCs into osteoblasts, adipocytes, and chondrocytes validates the multi-potent nature of DPSCs.
The doubling time of DPSCs was consistent with that reported for mesenchymal stem cells, suggesting a healthy and proliferative cell population. The flow cytometry analysis showed that a majority of the DPSCs were positive for CD-90, CD-73, and CD-105, confirming their identity as mesenchymal stem cells. Moreover, less than 2%of the cells were positive for CD-34, CD-45, and HLADR, confirming the absence of significant hematopoietic or endothelial cell contamination.
Overview
This protocol emphasizes the extraction, culture, and preservation of multipotent stem cells from dental pulp through enzymatic digestion. It demonstrates their potential to differentiate into osteoblasts, adipocytes, and chondrocytes.
Key Study Components
Area of Science
- Stem cell biology
- Dental pulp research
- Tissue engineering
Background
- Multipotent stem cells have significant potential in regenerative medicine.
- Dental pulp is a rich source of stem cells.
- Enzymatic digestion is a common method for isolating these cells.
- Understanding differentiation potential is crucial for therapeutic applications.
Purpose of Study
- To extract and culture multipotent stem cells from dental pulp.
- To assess the differentiation capabilities of these stem cells.
- To establish a reliable protocol for stem cell extraction and preservation.
Methods Used
- Securing the extracted human tooth with dental forceps.
- Cutting the tooth using a diamond disc and dental handpiece.
- Removing pulp tissue with a dental excavator.
- Digesting minced pulp tissue with collagenase type one and dispase.
Main Results
- Successful extraction of multipotent stem cells from dental pulp.
- Cells demonstrated the ability to differentiate into osteoblasts, adipocytes, and chondrocytes.
- Protocol ensures precision and consistency in stem cell culture.
- Potential applications in regenerative medicine highlighted.
Conclusions
- The protocol provides a reliable method for stem cell extraction.
- Multipotent stem cells from dental pulp have significant differentiation potential.
- Further research could explore therapeutic applications in tissue engineering.
Frequently Asked Questions
Executive Industry Relevance
Reliable isolation and characterization of dental pulp stem cells (DPSCs) enables biopharma teams to access a robust, multipotent cell source for early-stage regenerative medicine research. Standardized protocols for DPSC extraction and validation reduce biological ambiguity and support predictive confidence in downstream differentiation and functional assays. This capability strengthens the translational pipeline by providing reproducible, well-characterized cellular models for therapeutic hypothesis testing and preclinical evaluation.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of stem cell differentiation pathways relevant to regenerative targets.
- Supports biological de-risking by confirming mesenchymal stem cell identity via flow cytometry.
- Facilitates predictive confidence in multipotency through validated tri-lineage differentiation.
Screening & Assay Development
- Provides a standardized source of DPSCs for assay development and compound screening.
- Ensures reproducibility through quantitative marker analysis and controlled culture conditions.
- Delivers validated cell populations for scalable, platform-ready screening workflows.
Translational & Preclinical Research
- Aligns with disease-relevant regenerative models by enabling differentiation into osteoblasts, adipocytes, and chondrocytes.
- Supports continuity from discovery to preclinical validation with well-characterized stem cell populations.
- Reduces translational risk by confirming absence of hematopoietic or endothelial contamination.
Pipeline & Workflow Integration
This protocol positions DPSC isolation and characterization at the interface of early discovery and preclinical model development, supporting both target validation and translational research.
- Discovery Biology: Validates stem cell identity and multipotency, supporting hypothesis-driven regenerative research.
- Screening: Supplies reproducible, marker-confirmed DPSCs for assay standardization and compound evaluation.
- Analytics: Employs flow cytometry and colorimetric staining for quantitative assessment of cell identity and differentiation.
- Translational Research: Enables generation of disease-relevant cell types for preclinical studies.
- Enterprise Reuse: Establishes a reusable protocol for consistent DPSC sourcing across projects and teams.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in regenerative research.
- Operational Value: Delivers standardized, reproducible, and scalable DPSC isolation and validation.
- Strategic Value: Improves go/no-go decisions and capital efficiency by ensuring high-quality cellular inputs.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of regenerative medicine programs.
Implementation Considerations
- Requires expertise in tissue handling, enzymatic digestion, and cell culture techniques.
- Needs access to flow cytometry and colorimetric staining infrastructure for cell characterization.
- Demands cross-team standardization of isolation and validation protocols for reproducibility.
- Adaptation may be needed for different tooth sources or donor variability.
- Cell yield and purity depend on precise execution of enzymatic digestion and marker analysis.
